BI 894999 First in Human Dose Finding Study in Advanced Malignancies
Clinical trial NCT02516553 · COMPLETED
Trial details
- NCT number
- NCT02516553
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-08
- Primary completion
- 2021-11-23
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.